Ariel Johnson, PhD
Board Member
Ariel Johnson brings together a wealth of experience across investor relations, strategy, and marketing. She is the Vice President of Strategy and Investor Relations for Endotronix. Dr. Johnson has a PhD in Oral Biology from the University of Illinois at Chicago, a M.S. in Chemistry from the University of Minnesota and a B.S. and B.A. in Chemistry, Biology and Physiology from the University of Minnesota.
She is excited to work on the board to ensure our community (and all cardiology patients) get the best possible cardiology care and MHIF is working to provide access to innovative, state-of-the-art technology to enable the best possible outcomes for the patients.
